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Abstract
Interindividual variations in skeletal muscle metabolism make comparative analyses difficult. In this study, we have addressed the issue of
capturing the variability of metabolic performance observed during muscle exercise in humans by using an original method of normalization.
Metabolic changes induced by various kinds of exercise were investigated using 31P magnetic resonance spectroscopy (MRS) at 4.7 T in 65
normal subjects (23 women and 42 men) and 12 patients with biopsy-proven muscular disorders. Large variations in the extent of PCr
breakdown and intracellular acidosis were recorded among subjects and exercise protocols. For all the data pooled, the amplitude of
mechanical performance accounts for 50% of these variations. When scaled to the work output, variations of PCr consumption account for
65% of pH changes through a linear relationship. This linear relationship was substantially improved (90%) when both variables were scaled
to the square of work output performed (P1 and P2). By capturing most of the initial interindividual variability (90%), P1 vs. P2 relationship
represents an ideal standardization procedure, independent of any anthropometric measurements. This relationship also discloses a significant
link between the extent of PCr breakdown and intracellular acidosis regardless of exercise protocol. Moreover, changes in the slope of the P1
vs. P2 regression curve, as measured in old subjects and in selected patients, directly reflect alterations of energy production in muscle.
D 2002 Published by Elsevier Science B.V.
Keywords: Human muscle; Muscle physiology; Energy metabolism; 31P magnetic resonance spectroscopy; Muscular disease
A large interindividual variability of exercise-induced
metabolic changes is usually observed in humans. For
example, the rates of PCr breakdown and recovery, as
measured by 31P magnetic resonance spectroscopy (MRS),
can differ by a factor of two among normal subjects [1]. A
normalization procedure is then required if reliable compar-
isons among normal subjects or between patients and
controls have to be made. Over the years, different methods
have been used to take into account this high variability.
Their main purpose was to achieve the same relative
metabolic stress in subjects of different body size, sex,
age, training level and muscle capacity. Some of these
methods try out the normalization of metabolic variables
on the basis of anthropometric measurements such as
weight, height, body mass index (BMI), lean body-mass
(LBM) [2,3], muscle cross-sectional area [4] and muscle
volume [5,6]. Overall, these methods assume that the
mitochondrial density per liter of muscle and the supporting
intermediary metabolism are proportional to anthropometric
variables. This assumption may be true in healthy subjects
but cannot unquestionably be invoked when studying
muscle myopathies, drug treatments or genetically linked
conditions. Measurements of maximum voluntary contrac-
tion (MVC) have also been used as a normalization proce-
dure with the underlying hypothesis that the magnitude of
metabolic changes recorded during exercise is related to the
capacity of producing force and then to muscle mass [7,8].
Although widely used, this normalization procedure has
never been thoroughly analyzed in terms of reduction of
variability between subjects.
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An alternative strategy to help capture individual differ-
ences is to find relationships among metabolic variables
reflecting the intrinsic properties of muscle fibers. These
relationships should be independent of exercise intensity,
exercise capacity of subjects and of any other variables that
could interfere with exercise-induced metabolic changes.
Such an approach is limited by the variety of paradigms that
can be designed and by the direct impact that these para-
digms generally have on metabolic changes. We have
already described criteria of metabolic normality reducing
natural diversity [9] and used them to compare healthy
subjects [9] and patients with muscular disorders [10–12].
In the present study, we have addressed the issue of
capturing natural variability by using a two-step method for
normalization, based on measurements of metabolic and
mechanical parameters. The internal consistency of this
approach has been first verified in a group of 65 normal
subjects who performed different exercise protocols and
secondly tested in a group of patients with biopsy-proven
McArdle’s disease and mitochondrial myopathies.
1. Subjects
Sixty-five subjects including 23 women and 42 men
volunteered to participate in this study which has been
approved by the Ethics Committee of the Timone Hospital
in Marseille. All of them gave their informed consent.
Twenty-four subjects were above the age of 50 years and
classified arbitrarily as old (O), 41 were under 50 years and
classified as young (Y). They were active but not engaged in
a specific training program.
Secondarily, five patients with McArdle’s disease (one
woman, four men) and seven patients with mitochondrial
myopathies (four women, three men) were analyzed in the
light of results obtained in controls. All of them had been
diagnosed on the basis of clinical symptoms, serum CK,
EMG and histological findings on muscle biopsies.
2. Methods
2.1. 31P magnetic resonance spectroscopy
31P MRS explorations of finger flexor muscles were
carried out as previously described [9] using a Bruker 47/
30 Biospec spectrometer interfaced with a 30-cm bore, 4.7 T
horizontal superconducting magnet. Subjects sat on a chair
by the magnet with their dominant arm resting in the magnet
bore. To ensure good venous return, the forearm was placed
approximately at the same height as the shoulder. Magnetic
field homogeneity was optimized by monitoring the signal
from the water and lipid protons at 200.14 MHz. Pulsing
conditions (1.8 s interpulse delay, 120 As pulse length) were
selected to optimize the 31P MRS signal obtained with a 50-
mm-diameter double-tuned surface coil positioned over the
flexor digitorum superficialis muscle. This coil can detect
signals arising from flexor digitorum superficialis and
profundus muscles. We have previously observed on T2-
weigted images and in agreement with others [13] that these
muscles are activated during finger flexions. Spectra were
time averaged over 1 min (32 scans) and sequentially
recorded during 3 min at rest, 3 min during exercise and
20 min throughout the recovery period.
2.2. Exercise protocols
Three different exercise protocols were used to obtain a
wide range of work output, PCr and pH changes. All of
them consisted in finger flexions performed at 1.5 s intervals
using a weight-pulley system as previously described [9].
The sliding of the weight was recorded using a displacement
transducer connected to a personal computer. Force was
measured using ATS software (SYSMA-France) and work
output (W ) was calculated for each minute of exercise.
Exercise duration and intensity were chosen to ensure
significant pH and [PCr] decrease in all subjects and the
completion of protocols.
Protocol no. 1 was performed by 65 control subjects and
11 patients, with women lifting a 4-kg and men a 6-kg weight
during 3 min. This protocol is routinely used in our depart-
ment to investigate patients suffering from myopathies [14].
It is well accepted by patients, short and informative.
Protocol no. 2 was performed by 14 control men and
consisted of a 3-kg weight-lifting exercise during 3 min (i.e.
50% of the charge lifted during the first protocol).
Protocol no. 3 was performed by 21 control men and
consisted of an incremental exercise based on lifting a
weight which was gradually increased by 1 kg every minute
from 1 to 6 kg.
2.3. Data analysis
Raw MR data were transferred to an IBM RISC 6000
workstation and processed using the NMR1 spectroscopy
processing software (New Methods Research, Syracuse,
New York, USA). First, Fourier transformation and decon-
volution of free induction decays corresponding to a line
broadening of 15 Hz were performed. Baseline correction
was obtained with baseline deconvolution using computer-
estimated filter size and flattening factors [15]. The area of
each resonance was measured by curve fitting of the
spectrum to Lorentzian lines.
Concentrations in phosphocreatine (PCr), inorganic
phosphate (Pi), adenosine triphosphate (ATP) and phospho-
monoesters (PME) were calculated. Values were corrected
for differential magnetic saturation and expressed as abso-
lute concentrations relative to ATP concentration measured
at rest (8.2 mmol/l of intracellular water) as previously
described [9]. Values at rest were averaged over the three
first spectra. Intracellular pH was calculated from the Pi
signal chemical shift relative to PCr [16]. The free concen-
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tration of cytosolic ADP was also calculated from the
creatine kinase equilibrium:
½ADP ¼ ½ATP½Cr=Keq½PCr½Hþ
with Keq = 1.66 109 mol/l, assuming a normal total crea-
tine content of 42.5 mM.
The end-points of pH (pHe) and [PCr] ([PCr]e) were
calculated. These variables were scaled to the work output
and then to the square of work output (W2), to magnify the
impact of work output. The scaled variables were called E1
for pHe/W, E2 for [PCr]e/W, P1 for pHe/W2 and P2 for
[PCr]e/W2.
2.4. Statistics
All data are reported as meansF S.D. Comparisons
between protocols were made using analysis of variance
with the Student–Newman–Keuls and Fisher PLS tests for
multiple comparisons when necessary. Given the limited
number of patients, the non-parametric Mann and Whitney
test was used to compare results of patients and controls.
The relationships between quantitative variables were
determined from linear regression analysis and the Pearson
correlation coefficient. The data obtained for each protocol in
control subjects were analyzed separately and on pooled data
considering, as it is well accepted that pH and [PCr] changes
observed in a subject depend also on protocol designs and
can somehow be considered as random variables.
A significance level of P < 0.05 was selected for all tests.




The anthropometric characteristics of subjects are pre-
sented in Table 1.
3.1.1. Metabolic variables and work output
Variables measured at rest including pH, [PCr]/[Pi] and
[PCr]/[ATP] ratios were in agreement with previous studies
[17]. The comparison of men and women or old and young
subjects did not show any significant differences (Table 1).
Generally, old men and women developed less work than
their younger counterparts (Table 2). For the two other
protocols, only performed by men, the total work output
is presented along with the results of the first protocol (Table
3). The highest total work output was observed in the first
protocol (6 kg—3 min).
Whatever the exercise protocols, the values of pH and
PCr reached at end of exercise (pHe and [PCr]e) varied
greatly among subjects. These variations do not permit to
separate men from women or old and young subjects in the
protocol no. 1 (Table 2). Interestingly, the concentration of
free ADP calculated from the creatine kinase equilibrium at
the end of exercise (Tables 2 and 3) was independent of the
experimental protocols (Table 3).
3.1.2. Standardization with raw variables
pHe and [PCr]e were linearly and significantly linked as
shown in Table 4 and in Fig. 1A and considering the pooled
data, changes in [PCr] explained 65% of the variance
measured for the changes in pH. To determine the variability
due to work output, we have analyzed the relationship
between each parameter and the mechanical performance
(Table 4). As expected, an increase in work output induced a
larger drop in pH and PCr consumption regardless of the
exercise protocols. For the pooled data, around 50% of the
variance of each parameter is explained by changes in work
output.
Table 1
Anthropometric characteristics and metabolic variables of the 65 volunteers
at rest
n Men Women Young Old
42 23 41 24
Anthropometric variables
Height (cm) 178.2F0.9 161.4F1.3a 176.4F1.3 165.3F1.8b
Weight (kg) 77.8F1.3 57.9F1.7a 72.9F2 67.2F2.4
BMI 24.5F0.4 22.3F0.7a 23.3F0.5 24.5F0.6b
Metabolic variables
[PCr]/[Pi] 12.2F0.7 11.7F1.3 12.2F0.8 11.7F1.2
[PCr]/[ATP] 4.4F0.1 4.3F0.2 4.4F0.1 4.4F0.1
pH 6.99F0.004 6.99F0.007 6.99F0.004 6.99F0.005
a Significant differences between men and women ( P < 0.05).
b Significant differences between old and young subjects ( P< 0.05).
Table 2
Values of different variables in each subgroup (men, women, old and
young) of the first protocol, which consists in a 6-kg weight-lifting for men
and a 4-kg weight-lifting for women during 3 min
n Men Women Young Old
42 23 41 24
Metabolic variables measured at end of exercise
pHe 6.50F0.04 6.56F0.05 6.48F0.04 6.60F0.05
[PCr]e (mM) 15.2F1.1 16.8F1.5 15.1F1.2 16.9F1.5
[ADP]e (AM) 41F4.6 34.6F4.3 38.3F4 39.4F5.9
W (total work output) (J) 290F15a 139.5F11 284F16b 155F14
Metabolic variables calculated at end of exercise
E1 (pHe/W ) 4 10
(pH unit J 1)
1.01F0.06a 2.1F0.2 1.03F0.06b 2.03F0.17
E2 ([PCr]e/W ) 102
(mM J 1)
6.2F0.7a 14.2F0.8 6.4F0.8b 13.5F1.7
P1 (pHe/W 2) 104
(pH unit J 2)
1.1F0.2a 4.8F0.7 1.16F0.14b 4.5F0.7
P2 ([PCr]e/W 2) 104
(mM J 2)
2.8F0.5a 13.3F2.3 3.1F0.6b 12.4F2.3
Results are presented as meanF S.E.
a Significant differences between men and women ( P< 0.05).
b Significant differences between old and young subjects ( P< 0.05).
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3.1.3. Standardization with scaled variables
In an attempt to overcome the natural variability of the
previous relationships, we have tested pH and [PCr]
changes scaled to the work output and to the square of
work output. This scaling procedure allows to evaluate pH
and [PCr] changes for a standardized work output of 1 J. We
have calculated and compared the following four variables
E1 (pH/W ), E2 ([PCr]/W ), P1 (pHe/W 2) and P2 ([PCr]e/W 2)
as alternative variables. The square of work output was
tested to amplify variations in the mechanical parameter.
Finally, relationships were searched among these variables.
All ratios are multiplied by different factors to obtain data
around unity to simplify readings.
3.1.3.1. P1(pHe/W2) and P2 ([PCr]e/W2). P1 and P2 are
the pH and [PCr] values reached at the end of exercise and
normalized to the square of total work output (Tables 2
and 3). They can be considered as combined measures of
mechanical stress (work done) and metabolic strain (result-
ing pH and [PCr] changes). The lower the ratio, the higher
the mechanical stress and the metabolic strain. When
comparing results obtained in men throughout the three
protocols, P1 and P2 variables clearly indicate that the
muscle activity was more intense in the first protocol (6
kg—3 min) compared to the second (3 kg—3 min) (Table
3) as expected. Differences were also statistically signifi-
Table 3








n 42 14 21
Metabolic variables measured at the end of exercise
pHe 6.5F0.04a,b 6.85F0.04 6.71F0.05
[PCre] (mM) 15.2F1.2a,b 23.1F1.7 21.2F1.5
[ADPe] (AM) 41F4.6 36F5.1 36.5F5.2
W [work output (J)] 290F15a,b 146F10 187F11
Metabolic variables calculated at the end of exercise
E1 (pHe/W ) 410
(pH unit J 1)
1.01F0.06a,b 1.9F0.1c 1.5F0.1
E2 ([PCr]e/W ) 102
(mM J 1)
6.2F0.7a,b 17.4F2c 12.6F1.4
P1 (pHe/W 2 ) 104
(pH unit J 2)
1.1F0.2a,b 3.8F0.5c 2.4F0.3
P2 ([PCr]e/W 2) 104
(mM J 2)
2.8F0.5a,b 13.7F2.3c 8.1F1.4
Results were considered significant for a P-value < 0.05.
a Significant differences between protocols 1 and 2.
b Significant differences between protocols 1 and 3.
c Significant differences between protocols 2 and 3.
Table 4














Correlation between pH and [PCr] variables
pHe [PCr]e 0.57 0.66 0.56 0.65
Correlation between pH and [PCr] variables and work output
pHe W 0.35 0.81 0.54 0.48
[PCr]e W 0.35 0.54 0.44 0.44
Correlation between normalized variables
E1 vs. E2 0.84 0.90 0.83 0.84
P1 vs. P2 0.93 0.97 0.92 0.92
All results are statistically significant.
Fig. 1. (A) Correlation between pHe and [PCr]e variables in 65 patients
(protocol no. 1). pHe = 6.23 + 0.019[PCr]e, r = 0.57. (B) Correlation between
P1 (pHe/W2) and P2 ([PCr]/W2) in 65 patients (protocol no. 1).
P1 = 0.469 + 0.298P2, r= 0.93.
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cant between the first protocol and the incremental one
suggesting a larger metabolic and mechanical activity of
the muscle when lifting a 6-kg weight during 3 min than
when lifting incremental charges during 6 min. In addition,
P1 and P2 showed higher muscle activity in the incre-
mental protocol when compared to the protocol with lifting
a 3-kg weight, despite a similar level of total work output
(Table 3).
By taking into account the impact of work output on the
variability observed during exercise, P1 and P2 are variables
sensitive enough to distinguish men from women and old
from young subjects (Table 2) while [PCr]e and pHe are not
to enable such a distinction. Old subjects have higher ratios
indicating a reduced fiber activity when compared to young
subjects.
A highly significant correlation was observed between
P1 and P2 regardless of the exercise protocols (Table 4). The
comparison of the P1 vs. P2 relationship to the pHe vs.
[PCre] correlation clearly illustrated the significant reduc-
tion of variability obtained by standardization to the squared
work output (Fig. 1B). For the pooled data, 90% of the
variance of P1 was explained by the changes in P2. This
result confirms that the direct relationship, which exists
between pH and [PCr] reached at the end of exercise, is
reinforced when taking into account work output.
The slope of the P1 vs. P2 curve was similar in the
three protocols (Fig. 2). The slope of the regression curve
was higher in old subjects regardless of sex. On the
contrary, when analyzed separately in men and in women,
the two correlation curves were strictly parallel (Fig. 3A
and B).
3.1.3.2. E1 (pHe/W) and E2 ([PCr]e/W). E1 and E2 are
the pH and [PCr] values reached at the end of exercise and
normalized to work output. Overall, the results obtained
with these variables were similar to those obtained with P1
and P2 (Tables 2 and 3). However, for normalization
purposes, the P1 vs. P2 relationship tended to be better than
the E1 vs. E2 relationship.
Fig. 2. Correlation between P1 and P2 in men for the three protocols. The
slopes are similar. P1 = 0.348 + 0.268P2, r = 0.93 (protocol 6 kg), n= 42;
P1 = 1.127 + 0.197P2, r = 0.97 (protocol 3 kg), n= 14; P1 = 0.701 + 0.209P2,
r = 0.92 (protocol 1–6 kg), n= 21.
Fig. 3. (A) In men and women subgroups, slopes are strictly parallel.
P1 = 1.21 + 0.27P2, r = 0.90 (women); P1 = 0.348 + 0.27P2, r = 0.88 (men).
(B) In old and young subject subgroups, slopes are significantly different. A
steeper slope indicates a more intense metabolic strain to maintain cellular
homeostasis with a probable lesser activity of the glycogenolytic pathway.
P1 = 0.526 + 0.207P2, r = 0.88 (young); P1 = 0.963 + 0.289P2, r = 0.92 (old).
Table 5






pHe 6.5F0.04 7.1F0.05a 6.4F0.1
[PCr]e (mM) 15.1F1.2 6F0.9a 16.4F4.6
W [total work output (J)] 284F16 174F38a 173F21b
P1 (pHe/W 2) 104
(pH unit J 2)
1.2F0.1 3.4F0.9a 2.9F0.8b
P2 ([PCr]e/W 2) 104
(mM J 2)
3.1F0.6 2.9F0.8 5.9F1.9b
a Significant differences observed when comparing patients with
McArdle’s disease to controls.
b Significant differences observed when comparing patients with
mitochondrial myopathies to controls.
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3.2. Patients
To evaluate the usefulness of these variables in clinical
situations, we have tested them in well-defined cases of
McArdle’s disease and mitochondrial myopathies.
3.2.1. McArdle’s disease
Variables measured at end of exercise are summarized in
Table 5. As expected, an abnormal lack of acidosis was
recorded in these patients during exercise as a result of the
glycogen phosphorylase deficiency. Also, the extent of PCr
breakdown was significantly larger in patients.
P1 and P2 were tested separately as descriptive variables
and compared to the results of 41 age- and sex-matched
controls (Table 5). On average, P1 was significantly higher
in patients than in controls. P2 was similar in both groups
according to the lower work output and the larger PCr
changes measured in patients. However, a similar ratio for a
lesser work output indicated higher metabolic activity in
patients.
The relationship between P1 and P2 displayed a steeper
slope than in controls largely due to the lack of acidosis
during exercise (Fig. 4A). Due to the limited number of
subjects, P1 vs. P2 correlation calculated by non-parametric
test was not significant (r= 0.6; P < 0.2). However, such a
high slope clearly indicated the failure of the patients to
reach a significant acidosis during exercise.
3.2.2. Mitochondrial myopathies
Values measured at end of exercise are summarized in
Table 5. [PCr] and pH measured at the end of exercise were
not different from controls when work output was not taken
into account.
Again, P1 and P2 were tested separately as descriptive
variables and compared to the results of the 41 age- and sex-
matched controls (Table 5). They were both significantly
higher than in controls. As they take into account the work
output, P1 and P2 displayed a higher sensitivity than [PCr]e
and pHe to distinguish patients from controls.
In mitochondrial myopathies, the slope of the P1 vs. P2
curve is very low. No significant correlation between P1
and P2 was noted due to the small number of patients
(Fig. 4B).
4. Discussion
We have demonstrated in the present study that P1 (pHe/
W 2) and P2 ([PCr]e/W 2) are combined measures of mechan-
ical stress and metabolic strain providing simultaneous
information on mechanical and metabolic activities of
muscle fibers. The lower the ratio, the higher the mechanical
and metabolic stress. By taking into account mechanical
performances, P1 vs. P2 relationship highly improves the
link between the PCr and pH values measured at the end of
exercise. This relationship which is independent of exercise
protocols and captures most (90%) of the initial variability
can be used as a normalization procedure.
4.1. The issue of normalization
Although normalization of protocols and definition of
invariants are important prerequisites for any comparison
between subjects with different physical activity, variables
used so far have not provided convincing results for the
reduction of intersubject variability. Most of them present
drawbacks for a concomitant use in clinical and/or physio-
logical situations. The normalization by anthropometric
variables such as LBM, muscle cross-sectional area or
muscle volume [5,6] presumes that the activated muscle
volume is an approximation of the whole muscle maximum
power (MMP) and, thereby, that the amount of mitochondria
per cubic centimeter of muscle and the supporting interme-
diary metabolism are constant. This normalization proce-
dure also presupposes that the activated muscles can be
properly identified, consistently stimulated, and that neither
Fig. 4. (A) P1 vs. P2 correlation in patients with McArdle’s disease and in
an age- and sex-matched control subgroup. The steeper slope in the
McArdle’s group reflects the minor contribution of glycogenolysis to
muscle metabolism. P1 = 0.657+0.943P2, r = 0.85 (McArdle’s disease);
P1 = 0.53 + 0.207P2, r = 0.88 (protocol no. 1). (B) P1 vs. P2 correlation in
patients with mitochondrial myopathies and in an age- and sex-matched
control subgroup. The slighter slope in the mitochondrial myopathies group
reflects the minor contribution of oxidative pathways to muscle
metabolism. P1 = 2.47 + 0.078P2, r = 0.18 (mitochondrial myopathies);
P1 = 0.53 + 0.207P2, r = 0.88 (protocol no. 1).
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blood flow nor oxygen supply does limit submaximal
metabolic rates. This whole set of assumptions may be a
serious limitation when exploring muscle myopathies, drug
treatments, or genetically linked conditions. An alternative
approach for estimating MMP in individuals of different
body size is to determine the force generated during a MVC.
The MVC is often used because it is a relatively easy
parameter to measure. MVC as an estimate of MMP
assumes that individuals are highly compliant, that all
muscle fibers are activated by voluntary effort, and that no
antagonist muscles contract concurrently to reduce force
output. These assumptions are controversial for most human
subjects. Moreover, MVC measurements cannot generally
be performed just before a metabolic investigation to avoid
potential effects on the exercise-induced changes [18]. Also,
a recent study combining electromyographic and metabolic
measurements has clearly shown a large intersubject varia-
bility despite normalization of exercise intensity using MVC
[8].
The standardization procedure reported in the present
study is part of alternative strategies aiming at finding
internal relationships between metabolic variables [19–
21]. In that context, it has been proposed for example that
the intracellular threshold found during incremental exercise
could be used as an index of aerobic capacity [20]. This
threshold is defined as a deviation from linearity in pH with
respect to [PCr] changes during exercise. However, it is not
always detected when using ramp or step-type exercises
[20] and may not be applicable to certain diseases, such as
hypertension [22], or some cases of mitochondrial myopa-
thies [14], where proton efflux (and therefore intracellular
pH) is affected.
P1 and P2 are determined by various metabolic compo-
nents and by mechanical activity. P2 takes into account the
[PCr] level reached at the end of a mixed exercise, a level
determined by both anaerobic and aerobic ATP production.
On the other hand, muscle acidosis captured by P1 is a
complex process resulting from the handling of protons by
muscular cells [23]. Buffering components including Pi,
bicarbonate and non-Pi non-bicarbonate moieties limit intra-
cellular acidosis in the same way as proton efflux and PCr
hydrolysis. On the contrary, glycogenolytic activation
results in lactate production thereby increasing proton con-
centration in the cells when coupled to ATP hydrolysis. The
correlation between P1 and P2 indicated that, for a given
work output during exercise, the end-point pH determines
the end-point [PCr] and inversely.
The scaling of pH and [PCr] to the square of work output
modulates the extreme variability of their changes by taking
into account the large impact of work output on their
respective level at the end of exercise. The use of squared
quantities, like W2, as the denominator in ratios has two
advantages: it gives a higher weight to this quantity and it
reduces the occurrence of identical values of ratios, there-
fore enlarging the possibilities of comparison. An analogous
ratio (BMI) is currently used to compare the weight and size
of subjects. This standardization procedure enables to dis-
tinguish men and women, old and young subjects. The pH
and [PCr] end-points were unable to do so, whereas these
categories of healthy subjects are known to be metabolically
different [24–27].
In mitochondrial myopathies, P1 and P2 are higher than
in controls as a result of the reduced work output. According
to the results presented in Table 5, P1 and P2 are more
sensitive and discriminating than [PCr] and pH measured at
end of exercise to separate patients from controls. When
applied to typical McArdle’s disease, P1 clearly enables the
distinction between patients and age-matched controls, as a
result of the lack of acidosis taking into account the work
output. In contrast, P2 parameter does not separate patients
from controls while [PCr]e does.
These results show that the utilization of P1 and P2 in
metabolic analysis is generally more powerful than [PCr]e
or pHe to distinguish between subjects. It has to be
acknowledged that as ratios, P1 and P2 can hide an anomaly
when concomitant changes affect both numerator and
denominator. To eliminate this drawback, we have intro-
duced a second level of normalization based on a linear
relationship between these variables.
We have demonstrated a highly significant linear rela-
tionship between P1 and P2. This P1 vs. P2 correlation
indicates that each subject tends to reach a concomitant
limit of pH and [PCr] levels per Joule at end of exercise.
The relationship observed between P1 and P2 variables
reduces almost completely (90%) the intersubject variations
reported when exploring muscle metabolism by 31P MRS
during the exercise period. This reduction of intersubject
variability is not artificially due to the utilization of ratios
(related to W2 or W ). Indeed, there is no statistical law
indicating that a relationship between two variables should
be improved when these variables are divided by a random
third one. Even in the case of a relationship between the
first two variables and the third one, no statistical law has
ever suggested that the relationship should be invariably
improved. Actually, the strong correlation, observed
between two variables obtained at the end of exercise while
taking into account work output, likely reflects an intrinsic
property of muscle fibers. Concomitant changes between
[PCr] and pH have been previously reported during forearm
exercise [28]. Interestingly, averaged [ADP] measured at
end of exercise did not change among protocols although
exercise intensity was increased. It could be suggested that
various combinations of [PCr] and pH are multiple solu-
tions for muscle fibers to reach a given level or range of
ADP which in turn will act as a regulator of energy
production as previously described [23,29]. The internal
consistency of P1 vs. P2 correlation, demonstrated in the
group of 65 subjects, is confirmed by the persistence of the
relationship whatever the protocol used. Such a relationship
can then be used to compare exercise-induced metabolic
changes recorded in different subjects and for different
exercise protocols.
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In addition to the reduction in the extent of metabolic
changes, the analysis of P1 vs. P2 slopes provides additional
interesting information. The slope of the P1 vs. P2 regres-
sion curve was strictly similar among different experimental
protocols in men suggesting that any change of slope
indicates alterations of muscle energy production. An
increase of the slope of P1 vs. P2 regression curve indicates
a minor contribution of glycogenolysis; a decrease of the
slope indicates a minor contribution of oxidative pathways.
The comparison of old and young subjects showed that the
slope of the regression curve is higher for older subjects
independently of sex. The steeper slope measured in older
subjects indicates that for a given PCr consumption, the
magnitude of pH changes was smaller. This reduced acido-
sis has been already reported as a trend in old subjects [30]
and has to be linked with a different balance between
processes of proton generation and proton consumption in
muscle cells. On the contrary, when analyzed separately in
men and women, the two correlation curves were strictly
parallel. In McArdle’s disease, the P1 vs. P2 relationship
displays a steeper higher slope when compared to controls
clearly showing that for a given change in pH and a given
work output, the magnitude of [PCr] changes is much larger
in patients. Similarly, the steeper slope is accounted for by
the lack of acidosis during exercise, linked to the glycogen
phosphorylase deficiency. Such a difference in the slope of
the regression curve again suggests altered mechanisms of
energy production, with no contribution of glycogenolysis.
In mitochondrial diseases, nothing can be inferred with
certainty from the P1 vs. P2 relationship, likely as a result
of the large heterogeneity of this family of diseases rather
than a failure of the procedure. Actually, even the lack of
correlation between P1 and P2 parameters in this case can
be interpreted as a hint of a higher activity of the glyco-
genolytic pathways, likely to compensate alteration of
mitochondrial pathways. The global coherence of all these
indices reinforces the usefulness of P1–P2 relationship not
only as a normalization procedure but also as a simple index
reflecting changes and anomalies in muscle metabolism.
Overall, the analysis of muscle energetics using the P1
vs. P2 relationship permits to capture the complex mecha-
nisms involved in energy and force production and to
perform reliable comparisons among subjects. This analyt-
ical method needs no a priori assumptions on muscle
metabolism and can therefore be effective in various para-
digms of muscle testing, including training in normal sub-
jects and therapeutic monitoring in patients.
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